# 21 CFR Part 201, Subpart F—Labeling Claims for Drugs in Drug Efficacy Study

21 CFR Part 201, Subpart F—Labeling Claims for Drugs in Drug Efficacy Study, “Labeling Claims for Drugs in Drug Efficacy Study”, is a CFR division of [21 CFR Part 201—Labeling](https://ontology.bommaritollc.com/id/01a0f094-b837-76de-94de-1fdabf2c1fc1).

IRI: <https://ontology.bommaritollc.com/id/01a0f094-b5a3-701f-a765-9baefb8ea0b9>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter C—DRUGS: GENERAL](https://ontology.bommaritollc.com/id/01a0f094-b59c-71c5-9205-607bcccd7551) › [21 CFR Part 201—Labeling](https://ontology.bommaritollc.com/id/01a0f094-b837-76de-94de-1fdabf2c1fc1)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-division 21 CFR Part 201, Subpart F](https://ontology.bommaritollc.com/id/01a0f094-b5aa-7634-9007-dbb185c403a1)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-b5a3-701f-a765-9bad3d09ea39)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-d934-77ad-b64e-2e1f68fd033d)
- `schema:isPartOf`: [21 CFR Part 201—Labeling](https://ontology.bommaritollc.com/id/01a0f094-b837-76de-94de-1fdabf2c1fc1)
- `schema:legislationIdentifier`: 21 CFR Part 201, Subpart F
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationType`: [CFR division](https://ontology.bommaritollc.com/vocab/leg/cfrDivision)
- `schema:name`: Labeling Claims for Drugs in Drug Efficacy Study
- `skos:prefLabel`: 21 CFR Part 201, Subpart F—Labeling Claims for Drugs in Drug Efficacy Study

## Elsewhere

- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Parts (1; `schema:isPartOf`):
  - [21 CFR 201.200 Disclosure of drug efficacy study evaluations in labeling and advertising.](https://ontology.bommaritollc.com/id/01a0f094-c348-779d-ac15-622003632be9)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-b5a3-701f-a765-9baefb8ea0b9.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-b5a3-701f-a765-9baefb8ea0b9.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-b5a3-701f-a765-9baefb8ea0b9.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-b5a3-701f-a765-9baefb8ea0b9)
Cite as: 21 CFR Part 201, Subpart F—Labeling Claims for Drugs in Drug Efficacy Study. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-b5a3-701f-a765-9baefb8ea0b9
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
